Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 31, 2015 5:41 AM ET

Pharmaceuticals

Company Overview of Mallinckrodt LLC

Company Overview

Mallinckrodt LLC manufactures and distributes products used in diagnostic procedures, and in the treatment of pain and related conditions. It offers addiction treatment products, and specialty generics and pharmaceuticals; and active pharmaceutical ingredients, including medicinal narcotics, acetaminophen/paracetamol, stearates, phosphates, and peptides, as well as analytical research samples for pharmaceutical companies and analytical laboratories. The company also supplies medical isotope technetium-99m; and radiopharmaceuticals, and contrast media and delivery systems. It serves customers in the United States and internationally. The company was founded in 1867 and is based in St. Louis, ...

675 McDonnell Boulevard

St. Louis, MO 63042

United States

Founded in 1867

12,265 Employees

Phone:

314-654-2000

Fax:

314-654-6511

Key Executives for Mallinckrodt LLC

Mallinckrodt LLC does not have any Key Executives recorded.

Mallinckrodt LLC Key Developments

Mallinckrodt Pharmaceuticals Wins Award Solicitation for Pharmaceutical Ampules

Alabama Department of Finance, Division of Purchasing has posted its intent to award solicitation on October 29, 2014, to Mallinckrodt Pharmaceuticals for pharmaceutical ampules - drugs for $13,630 per lot.

Mallinckrodt Pharmaceuticals Launches OptiSync Data Management System in US

Mallinckrodt Pharmaceuticals has launched the OptiSync data management system as a new technology in its Global Medical Imaging segment, in US. The OptiSync system is designed to help healthcare professionals efficiently collect and analyze radiology data from when a patient undergoes a contrast media-enhanced computed tomography (CT) diagnostic imaging procedure. The OptiSync system is used with the OptiVantage dual-head CT contrast delivery system, and allows users to verify and log patient and pharmaceutical information with the scan of a barcode. As injection data is collected, the OptiSync system transmits patient, drug, dose and administration information to HL7-based healthcare systems and automates patient record updates. By assembling a database that includes contrast media usage, spend, workflow and benchmarking across all users, scanners and facilities, the OptiSync system can help users identify areas where they can reduce errors, increase productivity or improve efficiency.

Nuvo Research Inc. Enters into Settlement Agreement with Mallinckrodt Inc

Nuvo Research Inc. has entered into a settlement agreement with Mallinckrodt Inc. for a litigation relating to Nuvo's license to Mallinckrodt of the right to market and sell Pennsaid and Pennsaid 2% in the US. Under the terms of the settlement agreement, Mallinckrodt will return all US rights to Pennsaid and Pennsaid 2% to Nuvo after a brief transition period and pay USD 10 million. Pennsaid is used to treat the signs and symptoms associated with knee osteoarthritis (OA). The drug combines the transdermal carrier (containing dimethyl sulfoxide, popularly known as DMSO) with 1.5% diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID) and delivers the active drug through the skin directly to the site of inflammation and pain. Pennsaid is currently marketed in the US by Mallinckrodt, in Canada by Paladin Labs Inc. and marketed under license and/or distribution agreements in Greece, Italy and the UK.

Similar Private Companies By Industry

Company Name Region
Boehringer Ingelheim Pharmaceuticals, Inc. United States
Cannabinoid Science Systems, Inc. United States
Envoy Therapeutics, Inc. United States
Merial Limited United States
ApopLogic Pharmaceuticals LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mallinckrodt LLC, please visit www.mallinckrodt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.